LEADING INNOVATION
SCIENCE : MEDICAL / RESEARCH / CELLULAR THERAPY
Comprehensive Cell Solutions ( CCS ) brings our hospital customers to the forefront of patient care . Through our skilled apheresis nurses , dedicated laboratory and perioperative technologists , pharmacists , and medical staff , we provide medical services expertise , including hemophilia , laboratory , clinical , and transfusion medicine services . CCS offers 24 / 7 clinical apheresis services in New York , New Jersey , Connecticut , Pennsylvania , and Missouri , and we have the technology to collect any kind of cells via apheresis — the removal of blood from the body , separation into components such as plasma or platelets , and the retransfusion of the cells ( used especially to remove antibodies in treating autoimmune diseases ).
Our dedicated transfusion medicine professionals provide a wide range of consultative services for patients with bleeding disorders such as von Willebrand Disease , hemophilia , rare factor deficiencies ( inherited bleeding disorders in which one or more clotting factors are not in the blood , are only in small amounts , or do not work properly ), and rare platelet disorders ( inherited bleeding disorders in which platelets lack a protein needed for blood to clot ).
NYBC ’ s Hematopoietic Stem Cell Service provides comprehensive support for bone marrow transplant physicians and their patients at hospitals nationwide . Our Pharmacy Services supplies a broad range of medications and services for patients with bleeding disorders , offering a multidisciplinary approach to caring for bleeding disorder patients .
LFKRI ’ s pioneering investigators have a remarkable depth of experience and expertise in their fields , and their research programs are supported with funding from federal , state , and industrial sources . Our key areas of research include :
• Transfusion Medicine : Developing new molecular approaches and tools to advance safer transfusions
• Hematology : Elucidating the molecular and cellular basis of hematological disorders
• Infectious Disease : Discovering new vaccines and developing prevention strategies against infectious diseases
• Epidemiology : Conducting behavioral , biomedical , clinical , and transfusion epidemiology , blood safety surveilllance , and statistical and data analysis
• Cell Therapy : Defining the utility of stem cells in transplantation and regenerative medicine
Founded in 1992 , the National Cord Blood Program ( NCBP ) is the first and largest public cord blood bank in the world . NCBP serves as a regional , national , and international cord blood and stem cell collection , processing , and storage operations leader . Since its founding , NCBP has banked more than 60,000 cord blood units . There have been over 30,000 cord blood transplants throughout the world , and NCBP has provided cord blood units for transplantation to more than 5,000 recipients . NCBP also provides cord blood units for research — small units not being used for transplantation are made available to scientists for important basic and applied cord blood stem and immune cell research .
13 / NYBCe COMMUNITY REPORT